Bromodomain-containing-protein-4 and cyclin-dependent-kinase-9 inhibitors interact synergistically in vitro and combined treatment reduces post-traumatic osteoarthritis severity in mice
T. Fukui, J. H.N. Yik, B. Doyran, J. Davis, A. K. Haudenschild, I. E. Adamopoulos, L. Han, D. R. Haudenschild
Dive into the research topics of 'Bromodomain-containing-protein-4 and cyclin-dependent-kinase-9 inhibitors interact synergistically in vitro and combined treatment reduces post-traumatic osteoarthritis severity in mice'. Together they form a unique fingerprint.